[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 21, 2000

Antiviral Agents for Influenza

Author Affiliations
  • 1University of Minnesota and Veterans Affairs Medical Center, Minneapolis
JAMA. 2000;283(23):3069-3070. doi:10.1001/jama.283.23.3068c

To the Editor: Dr Wenzel's Editorial1 regarding anti-influenza drugs could be interpreted as dismissing the "first-generation" agents amantadine and rimantadine in favor of the newer "second-generation" neuraminidase inhibitors oseltamivir and zanamivir. Following a brief mention of the approved indications for the older agents, he provides a detailed list of the limitations of amantadine and rimantadine. The implication seems to be that the older agents are flawed and obsolete.

First Page Preview View Large
First page PDF preview
First page PDF preview
×